Rakesh Patel, MD
Radiation Oncology · Los Gatos, CANPI 1992768519
Payments from drug & device makers
What this record shows
The money is spread across several categories — ownership interests (56.1%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. Icad, Inc accounts for 96.9% of it on its own, with 21 other manufacturers making up the rest. Reporting peaked in 2021 at $561,057 and has fallen 100.0% since, to $270 in 2025. Among radiation oncology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 71 payments — averaging $18,975 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Icad, Inc$1.3M
- Bioptics, Inc.$20K
- Varian Medical Systems, Inc.$19K
- Hologic Inc$750
- Endomagnetics Ltd$450
- Siemens Medical Solutions USA, Inc.$367
- plus $800 from 16 others
What the payments were for
- Consulting fees$298,75522%
- Speaking & faculty fees$269,99820%
- Grants$20,0001%
- Travel & lodging$5970%
- Food & beverage$1,8750%
- Ownership interest$756,00056%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Icad, Inc | 24 | $1,305,922 |
| Bioptics, Inc. | 1 | $20,000 |
| Varian Medical Systems, Inc. | 8 | $18,936 |
| Hologic Inc | 1 | $750 |
| Endomagnetics Ltd | 2 | $450 |
| Siemens Medical Solutions USA, Inc. | 3 | $367 |
| Lunit Americas, Inc. | 1 | $137 |
| Myriad Genetic Laboratories, Inc. | 6 | $137 |
| AstraZeneca | 6 | $113 |
| Pfizer | 5 | $101 |
| Amgen | 3 | $66 |
| Leica Microsystems Inc. | 1 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Seagen Inc. | 1 | $24 |
| Sanofi | 1 | $24 |
| Genentech USA, Inc. | 1 | $22 |
| Tactile Systems Technology Inc | 1 | $21 |
| Tesaro, Inc. | 1 | $19 |
| Eisai Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Other$16,735
- Radiation Oncology$2,201
- Magseed$450
- Varian Ethos Treatment Planning$179
- Magtrace$156
- AXXENT SURFACE CONTROLLER$137
How this compares
$1,347,225 in reported general payments places this provider in the 95th percentile of 627 radiation oncology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other radiation oncology in Los Gatos
- Gordon WongLos Gatos$39K
- Amir LavafPalm Springs$411K
- Albert ChangLos Angeles$290K
- Arya AminiDuarte$265K
- Rizwan NuraniApple Valley$220K
- Drew MoghanakiLos Angeles$183K
- Jyoti MayadevSan Diego$170K
- Percy LeeIrvine$125K
- Felix FengSan Francisco$99K
- Hyun KimDuarte$97K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.